Compounds > naltrexone

naltrexone and Liver Cirrhosis

naltrexone has been researched along with Liver Cirrhosis in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's2 (13.33)29.6817
2010's7 (46.67)24.3611
2020's5 (33.33)2.80

Authors

AuthorsStudies
Dehpour, AR; Emamgholipour, S; Golestani, A; Hosseini-Fard, SR1
Fomin, V; Goodman, RP; Luther, J; Patel, SJ; Schaefer, E; Shay, JES; Vannier, AGL1
Ayyala, D; Bottyan, T; Dodge, JL; Gonzalez, JL; Han, H; Pimienta, M; Stager, K; Stolz, A; Terrault, NA; Tien, C; Yoo, J1
Falker, C; Garcia-Tsao, G; Kaplan, DE; Mahmud, N; Rabiee, A; Taddei, T1
Brown, SA; Izzy, M; Watt, KD1
Allahabadi, NS; Dehpour, A; Hassanipour, M; Rahimi, N; Sabbaghziarani, F; Yazdanparast, M1
Harlos, MS; Hohl, CM; Wong, JK1
Bagherieh, M; Dehpour, AR; Doustimotlagh, AH; Golestani, A; Nourbakhsh, M; Sarhadi Kholari, F1
Dehpour, AR; Gharedaghi, MH; Ghiassy, B; Javadi-Paydar, M; Norouzi-Javidan, A; Rahimi, N1
Clemens, MG; Day, SA; Lakner, AM; Moore, CC; Schrum, LW; Wu, ES; Yen, MH1
Oberpichler-Schwenk, H1
Blum, HE; Kreisel, W; Opitz, OG; Thimme, R1
Fogel, WA; Stasiak, A1
Bertolotti, M; Carubbi, F; Carulli, N; Ferrari, A; Loria, P; Stefani, M; Sternieri, E; Trenti, T; Vitale, G1

Reviews

2 review(s) available for naltrexone and Liver Cirrhosis

ArticleYear
Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underused Potential.
    Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:5

    Topics: Anti-Obesity Agents; Bupropion; Drug Therapy, Combination; Humans; Liraglutide; Liver Cirrhosis; Liver Transplantation; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate; Translational Science, Biomedical

2021
[Cholestatic liver diseases].
    Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8

    Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruritics; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiography; Cholangitis; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Naloxone; Naltrexone; Narcotic Antagonists; Ondansetron; Plasmapheresis; Ursodeoxycholic Acid

2004

Trials

1 trial(s) available for naltrexone and Liver Cirrhosis

ArticleYear
Effect of liver cirrhosis on the systemic availability of naltrexone in humans.
    Journal of hepatology, 1997, Volume: 27, Issue:3

    Topics: Adult; Aged; Biological Availability; Female; Humans; Linear Models; Liver Cirrhosis; Male; Middle Aged; Naltrexone; Narcotic Antagonists

1997

Other Studies

12 other study(ies) available for naltrexone and Liver Cirrhosis

ArticleYear
Naltrexone protects against BDL-induced cirrhosis in Wistar rats by attenuating thrombospondin-1 and enhancing antioxidant defense system via Nrf-2.
    Life sciences, 2022, Jul-01, Volume: 300

    Topics: Animals; Antioxidants; Bile Ducts; Ligation; Liver; Liver Cirrhosis; Male; NADPH Oxidase 1; Naltrexone; Necrosis; Rats; Rats, Wistar; Thrombospondin 1; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A

2022
Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.
    JAMA network open, 2022, 05-02, Volume: 5, Issue:5

    Topics: Alcoholism; Baclofen; Female; Gabapentin; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Naltrexone; Retrospective Studies; Topiramate

2022
Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease.
    Hepatology communications, 2022, Volume: 6, Issue:12

    Topics: Adult; Alcoholism; Humans; Liver Cirrhosis; Liver Diseases; Naltrexone; Retrospective Studies

2022
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis.
    Hepatology communications, 2023, 04-01, Volume: 7, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Naltrexone; Retrospective Studies

2023
Cirrhosis induced by bile duct ligation alleviates acetic acid intestinal damages in rats: Involvements of nitrergic and opioidergic systems.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:3

    Topics: Acetic Acid; Analgesics, Opioid; Animals; Bile Ducts; Enzyme Inhibitors; Intestinal Mucosa; Intestines; Ligation; Liver Cirrhosis; Male; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitrergic Neurons; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Opioid Peptides; Rats; Rats, Wistar; Receptors, Opioid

2018
KASL clinical practice guidelines: management of alcoholic liver disease.
    Clinical and molecular hepatology, 2013, Volume: 19, Issue:3

    Topics: Alcohol Abstinence; Alcohol Drinking; Alcohol-Related Disorders; Baclofen; Disulfiram; Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Humans; Liver Cirrhosis; Liver Diseases, Alcoholic; Naltrexone; Prevalence; Prognosis; Risk Factors; Severity of Illness Index; Surveys and Questionnaires

2013
Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease.
    Journal of palliative care, 2015, Volume: 31, Issue:2

    Topics: Aged; Carcinoma, Hepatocellular; Fatal Outcome; Female; Gallbladder Neoplasms; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Pruritus; Quaternary Ammonium Compounds; Terminal Care

2015
Erythrocytes Membrane Alterations Reflecting Liver Damage in CClâ‚„-Induced Cirrhotic Rats: The Ameliorative Effect of Naltrexone.
    Acta medica Iranica, 2016, Volume: 54, Issue:10

    Topics: Animals; Carbon Tetrachloride; Chemokine CCL4; Erythrocyte Membrane; Erythrocytes; Liver Cirrhosis; Male; Malondialdehyde; Naltrexone; Oxidative Stress; Rats; Rats, Wistar

2016
Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats.
    Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:1

    Topics: Animals; Drug Interactions; Hepatic Encephalopathy; Lipopolysaccharides; Liver; Liver Cirrhosis; Male; Naltrexone; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitrites; Rats

2017
Opioid-like compound exerts anti-fibrotic activity via decreased hepatic stellate cell activation and inflammation.
    Biochemical pharmacology, 2011, Apr-15, Volume: 81, Issue:8

    Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Collagen; Disease Models, Animal; Hepatic Stellate Cells; Immunoblotting; Liver Cirrhosis; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Morphinans; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction

2011
[Between cider and cirrhosis].
    Medizinische Monatsschrift fur Pharmazeuten, 2012, Volume: 35, Issue:8

    Topics: Alcohol Deterrents; Alcohol Drinking; Humans; Liver Cirrhosis; Magnesium Deficiency; Naltrexone; Proton Pump Inhibitors

2012
High voluntary alcohol consumption, in experimental liver cirrhosis is hardly responsive to opioid antagonist treatment.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2008, Volume: 59, Issue:1

    Topics: Alcohol Drinking; Animals; Behavior, Animal; Bilirubin; Brain; Disease Models, Animal; Drinking; Liver Cirrhosis; Male; Naloxone; Naltrexone; Narcotic Antagonists; Prothrombin Time; Radioligand Assay; Rats; Rats, Wistar; Receptors, Opioid, mu; Thioacetamide; Time Factors

2008